Compositions and methods related to xCT peptides
US11040223B2 · kind B2 · utility
0Cited by
2References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 16, 2020 |
| Grant date | Jun 22, 2021 |
| Priority date | — |
| Expiry date | Mar 16, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2795/00041
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Certain embodiments are directed to composition for inducing an immune response against xCT that is directed to cancer stem cells expressing xCT.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.